AN
Cellbxhealth PLC
ANPCF · OTC
$0.02 +0.00% (+$0.00)
Market Cap £16.7M
P/E Ratio -
Div. Yield -
ROE 343.50%
Piotroski F-Score Weak
2/9Valuation
25 /100
Expensive P/B 4.10x
P/S 9.71x
PEG N/A
Growth
78 /100
Growing Book val. growth 22.96%
Rev. growth 41.37%
FCF growth N/A
Profitability
0 /100
Weak FCF margin 761.66%
Op. margin 1,127.69%
Gross margin 283.61%
Quality
3 /100
Poor Asset turnover 0.22x
ROA 250.13%
ROIC 350.62%
Debt
68 /100
Low Current ratio 2.54x
Int. coverage -85.28x
Debt/Equity 0.32x
Stability
31 /100
Unstable Profitable years 0
EPS volatility 35.11%
Beta 0.41x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ANPCF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Peter Michael Collins
Employees
119
Headquarters
Guildford
Upcoming events
29 APR
Earnings
Upcoming earnings report